688289 圣湘生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.6623.8164.94827.92940.357
总资产报酬率 ROA (%)2.1183.2314.12723.81735.755
投入资产回报率 ROIC (%)2.3113.6274.84527.46839.555

边际利润分析
销售毛利率 (%)72.97677.91271.53958.83471.668
营业利润率 (%)15.85919.05142.44436.27458.074
息税前利润/营业总收入 (%)10.48512.02435.45035.12358.206
净利润/营业总收入 (%)13.01915.51934.57130.02549.673

收益指标分析
经营活动净收益/利润总额(%)98.58568.9616.158109.76596.776
价值变动净收益/利润总额(%)5.133-7.84276.8813.4223.097
营业外收支净额/利润总额(%)-9.753-6.587-4.138-1.031-0.213

偿债能力分析
流动比率 (X)4.8767.6706.4734.7888.986
速动比率 (X)4.4877.1506.0634.5628.430
资产负债率 (%)23.71114.62212.17518.10610.000
带息债务/全部投入资本 (%)16.8915.8471.0500.4830.949
股东权益/带息债务 (%)482.4951,587.0209,285.78020,361.48510,364.053
股东权益/负债合计 (%)317.757575.768699.630451.575898.257
利息保障倍数 (X)-2.645-2.056-6.679-44.984227.525

营运能力分析
应收账款周转天数 (天)138.442150.476351.35157.79152.447
存货周转天数 (天)327.777430.019459.63549.13390.945